• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA - PRINCETON DURASEAL EXACT SPINE SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL SPINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA - PRINCETON DURASEAL EXACT SPINE SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL SPINE Back to Search Results
Catalog Number 206520
Medical Device Problem Code Improper Chemical Reaction (2952)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/02/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An investigation has been initiated based on the reported information.Upon completion of the investigation, a follow-up report will be submitted.
 
Event or Problem Description
A facility reported that after injecting the blue solution of duraseal exact spine sealant system (206520) into the powder vial, it become jellied formation straight away.The product was in contact with the patient; however, there was no patient injury and no delay in surgery noted.
 
Event or Problem Description
N/a.
 
Additional Manufacturer Narrative
Updated fields.The duraseal exact spine sealant system (206520) was returned for evaluation: device history record (dhr) review - the dhr was reviewed, and no anomalies were found during the manufacturing and packaging process that could be related to the reported condition.Failure analysis - investigation showed that the product received included 2 syringes with 2 holder connectors (connected to external components), 3 loose spray tips, and 2 y-connectors.Loose spray tips, and y-connectors were visually inspected, and no signs of damage or usage were found.The assembly with syringes and holder connectors were visually inspected as well and had no signs of damage.There were signs of use as there were marks of dry blood and the syringes were received empty.The syringes were unscrewed to verify the tip and no discrepancies were detected.Vial was not included for evaluation and the syringes were received empty showing the product was used.With the sample available for evaluation, the failure mode reported could not be confirmed.Root cause - the root cause is undetermined.Product received was tested and the failure mode reported was not confirmed.Per the dfmea, potential causes of failure include: issues with solution mixing and coverage.The risk remains acceptable per the risk analysis.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURASEAL EXACT SPINE SEALANT SYSTEM 5ML US BOX OF 5
Common Device Name
DURASEAL SPINE
Manufacturer (Section D)
INTEGRA - PRINCETON
1100 campus road
1100 campus road
princeton NJ 08540
Manufacturer (Section G)
INTEGRA - PRINCETON
1100 campus road
none
princeton NJ 08540
Manufacturer Contact
vivian nelson
1100 campus drive
princeton, NJ 08540
6099362319
MDR Report Key21219231
Report Number3003418325-2025-00004
Device Sequence Number3378179
Product Code NQR
UDI-Device Identifier10381780000044
UDI-Public10381780000044
Combination Product (Y/N)N
PMA/510(K) Number
P080013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/26/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/30/2025
Device Catalogue Number206520
Device Lot Number60521863
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/03/2025
Supplement Date Received by Manufacturer02/11/2025
Initial Report FDA Received Date01/23/2025
Supplement Report FDA Received Date02/26/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
-
-